Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Neola Medical

2,4

 

SEK

 

0 %

Mindre end 1K følgere

NEOLA

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Sammenligne
0%
-2,04%
+5,26%
+18,81%
+9,09%
+20,6%
-7,46%
-
-56,76%

Neola Medical is active in medical technology. The company is focused on neonatal care, where they develop medical equipment. Examples of products the company provides to healthcare include technical monitoring and follow-up of the lung capacity of premature babies. In addition to the main product, ancillary products and disposable items are offered. The largest activity is found within the Nordic market. The company previously went by the name GPX Medical.

Læs mere
Markedsværdi
187,08 mio. SEK
Aktieomsætning
16,47 t SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Finanskalender
22.8
2025

Delårsrapport Q2'25

Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Pressemeddelelse22.5.2025, 10.59

Redeye: Neola Medical Q1 - Clinical progress on track

Neola Medical
Selskabsmeddelelse21.5.2025, 06.45

Neola Medical Q1 Report 2025 – Strengthened shareholder base with institutional investors ahead of clinical study start

Neola Medical
Pressemeddelelse21.5.2025, 05.00

First Patient Enrolled in Clinical Pilot Study with Neola® on Preterm Born Babies

Neola Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Pressemeddelelse8.5.2025, 05.15

Neola Medical Granted European Patent for Lung Monitoring, Strengthens Protection in Key Markets

Neola Medical
Pressemeddelelse22.4.2025, 10.30

Neola Medical named finalist for Sweden’s new global innovation award at World Expo 2025 in Japan

Neola Medical
Selskabsmeddelelse9.4.2025, 09.45

Neola Medical AB Publishes 2024 Annual Report

Neola Medical
Pressemeddelelse1.4.2025, 05.45

Neola Medical’s CEO shares spring milestones and strengthened shareholder base in 2025 investor letter

Neola Medical
Pressemeddelelse25.3.2025, 06.00

Neola Medical Signs Agreement with Södra Älvsborgs Sjukhus in Borås to Initiate Clinical Pilot Study on Preterm Born Babies

Neola Medical
Selskabsmeddelelse12.3.2025, 18.44

Neola Medical has completed a directed share issue of approximately SEK 20 million

Neola Medical
Selskabsmeddelelse12.3.2025, 16.31

Neola Medical intends to carry out a directed share issue of approximately SEK 20 million

Neola Medical
Pressemeddelelse5.3.2025, 06.00

Neola Medical Granted New Patent Family in China, Protection for Lung Monitoring

Neola Medical
Pressemeddelelse13.2.2025, 10.47

Redeye: Neola Medical Q4 - Vital clinical data incoming

Neola Medical
Selskabsmeddelelse12.2.2025, 06.45

Neola Medical Q4 Report 2024 – Received approval for initiation of first clinical pilot study on preterm born babies

Neola Medical
Pressemeddelelse11.2.2025, 06.00

Neola Medical receives approval by Swedish Authorities to initiate Clinical Pilot Study on Preterm Born Babies in Sweden

Neola Medical
Pressemeddelelse5.2.2025, 06.00

Neola Medical invites to presentation of the Q4-report 2024

Neola Medical
Pressemeddelelse9.1.2025, 06.00

Neola Medical to Participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco

Neola Medical
Pressemeddelelse18.12.2024, 06.00

Neola Medical’s CEO shares 2024 achievements in Winter Investor Letter

Neola Medical
Pressemeddelelse28.11.2024, 06.00

Neola Medical to present at Redeye Technology & Life Science Day

Neola Medical
Pressemeddelelse20.11.2024, 06.00

Neola Medical Live at Stora Aktiedagarna in Stockholm: Showcases Strategic Advancements for Market Launch in the U.S.

Neola Medical
Pressemeddelelse19.11.2024, 06.00

Neola Medical secures U.S. trademark of Neola® logo ahead of market launch

Neola Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.
  • Latest
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Dividends Calendar
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team